Latest News of NVCR
Even after rising 8.9% this past week, NovoCure (NASDAQ:NVCR) shareholders are still down 86% over the past three years
By Yahoo! Finance |
3 months ago
NovoCure Limited's stock price has recently surged by 40% in three months, showing a positive trend. However, over the past three years, the stock has plummeted by 86%....
NovoCure Limited (NVCR) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance |
5 months ago
Novocure shared promising results from the TIGER study on TTFields therapy for glioblastoma. The study included 429 patients in Germany, making it the largest non-interventional research on this treat...